Medicine Man Technologies
Logotype for Medicine Man Technologies Inc

Medicine Man Technologies (SHWZ) investor relations material

Medicine Man Technologies has been otc

Medicine Man Technologies Q2 2024 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Medicine Man Technologies Inc
Q2 2024 earnings summary13 Aug, 2024

Executive summary

  • Gained market share in Colorado and New Mexico, outperforming local markets year-over-year and quarter-over-quarter.

  • Achieved sequential quarterly growth across key financial metrics in Q2 2024, driven by growth and restructuring initiatives.

  • Focused on consumer needs, retail experience, and loyalty programs to drive customer acquisition and retention.

  • Implemented restructuring initiatives, including store closures and operational streamlining, to enhance profitability.

Financial highlights

  • Q2 2024 revenue increased 2% year-over-year to $43.2 million, primarily from new stores.

  • Gross profit was $19 million (44% margin), down from $23 million (54.4%) last year due to pricing pressure and product mix.

  • Operating expenses rose to $21.8 million from $18.1 million, driven by SG&A for five new stores and non-recurring professional fees.

  • Loss from operations was $2.7 million, compared to $5 million income last year; net loss widened to $13.9 million from $6.6 million.

  • Adjusted EBITDA was $9 million (21% margin), down from $13.8 million (33%) last year.

  • Cash and equivalents at $12.3 million as of June 30, 2024; total debt at $163.4 million.

Outlook and guidance

  • Expect continued growth and improved profitability in the second half of 2024.

  • Ongoing focus on refining retail strategy and driving operating efficiencies across retail, cultivation, and manufacturing.

  • Anticipate net new store growth in New Mexico to turn negative due to increased regulatory enforcement and closures.

  • Recent debt restructuring provides financial flexibility for strategic growth.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
Research faster. Power your platform.
Latest events from Medicine Man Technologies
    Medicine Man Technologies
    Cover every name on your watchlist this earnings season.
    Automations, AI chat, and live calls across 16,000+ companies.
    Book demo

    AI chat

    Ask anything. Verify everything.

    Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn more

    Find what matters

    AI across all first-party IR material. Live calls, transcripts, slides, filings.
    A cited source card from Adobe's CFO alongside a list of forward-looking statements

    Trust every finding

    50m+ first-party documents. Every output traceable to its source.

    Automations

    Zero in on what matters

    Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more
    An automation set to trigger on the first published earnings document for GE Aerospace

    Event-triggered research

    Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.
    An automation scheduled to run weekly on Mondays at 09:00

    Scheduled research

    Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.

    Live audio & transcripts

    Be first

    Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more
    A live LVMH Q2 2026 earnings call playing in Quartr

    Live earnings calls

    Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.
    A live transcript excerpt from LVMH's Chairman and CEO Bernard Arnault

    Live transcripts

    Speaker-by-speaker, in real time. Searchable across every live and historical call.

    Quartr MCP connects your AI environment to 17K+ public companies

    Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
    Included with Quartr Pro at no extra cost.Learn more

    Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.

    Jamie Ross

    Investment Manager, GAM Investments

    GAM
    GAM

    Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.

    Tom O'Hara

    Investment Director

    Ciena
    Ciena

    Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.

    Gregg Lampf

    VP of Investor Relations

    Frequently asked questions

    Medicine Man Technologies, Inc., doing business as Schwazze, is a cannabis company that operates within the cultivation, manufacturing, and retail sectors of the cannabis industry. The company provides a wide range of cannabis products, including flower, concentrates, edibles, and wellness products. Schwazze also offers consulting and operational support to cannabis businesses. Its focus is on expanding its retail footprint and vertically integrating its operations to streamline production and distribution. The company is headquartered in Denver, United States, and its shares are listed on the OTC Markets.